Channels - Insulin‐reducing effect of adding imeglimin to ongoing dipeptidyl peptidase‐4 inhibitor therapy with multiple daily insulin injections (INSPIRE study)

Similar Items: Insulin‐reducing effect of adding imeglimin to ongoing dipeptidyl peptidase‐4 inhibitor therapy with multiple daily insulin injections (INSPIRE study)

Quick Look
Monocyte dipeptidyl peptidase 4 activity is associated with urinary albumin excretion in type 2 diabetes
Quick Look
Pen Needle Reuse in People with Diabetes Who Inject Insulin: A Narrative Review
Quick Look
Efficacy and Safety of Insulin Efsitora Versus Degludec in Adults with Type 2 Diabetes Who Are Insulin-Naïve: Japan Subgroup Analysis of QWINT-2
Quick Look
Associations of finerenone with reduced insulin resistance in patients with type 2 diabetes and chronic kidney disease: A real‐world observational study
Quick Look
Effects of imeglimin on experimental diabetic neuropathy in streptozotocin‐induced diabetic rats
Quick Look
Sestrin-2: a new biomarker for type 2 Diabetes Mellitus and Insulin resistance
Quick Look
Role of the UHRF1–KLHL6–CORO2B axis in obesity‐related insulin resistance
Quick Look
Optimizing Type 2 Diabetes Management in Iraq: Expert Consensus on Initiation and Intensification of Insulin-Based Treatment Options
Quick Look
Correspondence: Effects of short‐term tofogliflozin treatment on insulin secretory capacity in type 2 diabetes: Insights and future directions
Quick Look
Basal Insulin Adherence in Patients with Type 2 Diabetes Mellitus in Routine Clinical Practice in Spain: Clinical and Economic Impact
Quick Look
Real-World Performance of the MiniMed 780G Advanced Hybrid Closed Loop Automated Insulin Delivery System in Greece
Quick Look
Real-time continuous glucose monitoring in adults with type 2 diabetes managed with non-intensive insulin regimens: impact on glycemia and self-management
Quick Look
Five‐year follow‐up of incretin‐based therapy in a patient with KCNJ11‐related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction
Quick Look
Cost‐effectiveness analysis comparing real‐time continuous glucose monitoring with self‐monitoring of blood glucose for patients with type 2 diabetes treated with insulin in Japan
Quick Look
Correction to “Effects of short‐term tofogliflozin treatment on the insulin secretory capacity of people with type 2 diabetes: A randomized controlled trial, the TOP‐2ELM study”
Quick Look
Twice-Weekly Oral Iron–Folic Acid Supplementation Is an Alternative to a Daily Regimen in Pregnancy: An Open-Label, Randomized, Active-Controlled, Noninferiority Trial
Quick Look
Sodium–glucose cotransporter 2 inhibition and injection burden in mild diabetic macular edema: An exploratory post hoc analysis of the COMET trial
Quick Look
Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management
Quick Look
Reduced Subfatin levels are independently associated with proliferative diabetic retinopathy, unlike Chromogranin-A
Quick Look
The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon: An Analytical Cross-Sectional Study
Quick Look
NEAT1: a multifaceted long non-coding RNA in multiple myeloma
Quick Look
Impact of SGLT2 Inhibitors on Clinical Outcomes in Patients with Diabetes Mellitus Following Heart Transplantation: A Meta-analysis
Quick Look
A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activity
Quick Look
A Rare Case Report of Immunoglobulin D Subtype Multiple Myeloma Complicated With Hyperlipidemia